|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.34 USD | +0.17% |
|
+2.87% | +1.48% |
| 07-28 | What to know about the US outbreak of cyclosporiasis intestinal illness | RE |
| 07-28 | Freshpet Poised to Deliver on Q2, Full-Year Financial Targets, Oppenheimer Says | MT |
Company Valuation: Walmart Inc.
Data adjusted to current consolidation scope
| Fiscal Period: January | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 387,816 | 387,989 | 444,892 | 788,557 | 949,566 | 900,059 | - | - |
| Change | - | 0.04% | 14.67% | 77.25% | 20.42% | -5.21% | - | - |
| Enterprise Value (EV) 1 | 415,887 | 423,986 | 481,916 | 825,310 | 990,362 | 948,712 | 948,993 | 950,889 |
| Change | - | 1.95% | 13.66% | 71.26% | 20% | -4.21% | 0.03% | 0.2% |
| P/E | 28.7x | 33.7x | 28.8x | 40.7x | 43.6x | 39x | 34.9x | 31.5x |
| PBR | 4.69x | 5.11x | 5.31x | 8.67x | 9.59x | 8.37x | 7.57x | 7.1x |
| PEG | - | -2.7x | 0.8x | 1.6x | 3.3x | 6.26x | 3x | 2.9x |
| Capitalization / Revenue | 0.68x | 0.64x | 0.69x | 1.17x | 1.34x | 1.2x | 1.14x | 1.09x |
| EV / Revenue | 0.73x | 0.7x | 0.75x | 1.22x | 1.4x | 1.26x | 1.21x | 1.15x |
| EV / EBITDA | 11.3x | 11.9x | 12.4x | 19.4x | 21.9x | 19.3x | 17.6x | 16.2x |
| EV / EBIT | 16x | 17.2x | 17.8x | 28x | 31.8x | 28.1x | 25.3x | 22.9x |
| EV / FCF | 37.6x | 35.4x | 31.9x | 65.2x | 66.4x | 84.1x | 58.5x | 50.5x |
| FCF Yield | 2.66% | 2.83% | 3.14% | 1.53% | 1.51% | 1.19% | 1.71% | 1.98% |
| Dividend per Share 2 | 0.7333 | 0.7467 | 0.76 | 0.83 | 0.94 | 0.9966 | 1.048 | 1.102 |
| Rate of return | 1.57% | 1.56% | 1.38% | 0.85% | 0.79% | 0.88% | 0.93% | 0.97% |
| EPS 2 | 1.623 | 1.423 | 1.913 | 2.41 | 2.73 | 2.9 | 3.24 | 3.595 |
| Distribution rate | 45.2% | 52.5% | 39.7% | 34.4% | 34.4% | 34.4% | 32.3% | 30.6% |
| Net sales 1 | 567,762 | 605,881 | 642,637 | 674,538 | 706,413 | 752,172 | 786,933 | 825,571 |
| EBITDA 1 | 36,708 | 35,547 | 38,865 | 42,477 | 45,185 | 49,084 | 53,790 | 58,742 |
| EBIT 1 | 26,050 | 24,602 | 27,012 | 29,504 | 31,096 | 33,725 | 37,562 | 41,519 |
| Net income 1 | 13,673 | 11,680 | 15,511 | 19,436 | 21,893 | 23,130 | 25,857 | 28,562 |
| Net Debt 1 | 28,071 | 35,997 | 37,024 | 36,753 | 40,796 | 48,654 | 48,934 | 50,830 |
| Reference price 2 | 46.60 | 47.96 | 55.08 | 98.16 | 119.14 | 113.10 | 113.10 | 113.10 |
| Nbr of stocks (in thousands) | 8,321,635 | 8,090,400 | 8,076,701 | 8,033,386 | 7,970,167 | 7,958,079 | - | - |
| Announcement Date | 17/02/22 | 21/02/23 | 20/02/24 | 20/02/25 | 19/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.13x | 1.23x | 10.77x | 0.93% | 54.2B | ||
| 21.31x | 0.62x | 11.82x | 2.53% | 40.74B | ||
| 16.14x | 0.55x | 8.07x | 3.19% | 40.73B | ||
| 11.72x | 0.34x | 6.19x | 2.49% | 36.26B | ||
| 12.81x | 0.49x | 6.15x | 3.63% | 35.04B | ||
| 46.1x | 0.9x | 10.55x | 2.37% | 33.91B | ||
| 23.52x | 0.78x | 6.62x | 1.31% | 28.59B | ||
| 52.63x | 0.63x | 10.59x | 1.03% | 24.01B | ||
| 25.82x | 0.66x | 12.83x | -.--% | 22.35B | ||
| Average | 26.58x | 0.69x | 9.29x | 1.94% | 35.09B | |
| Weighted average by Cap. | 25.50x | 0.72x | 9.25x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WMT Stock
- WMT Stock
- Valuation Walmart Inc.
Select your edition
All financial news and data tailored to specific country editions
















